Strong proof-of-concept results often stall during deployment, whether in generative molecular design, ADME prediction, or biomarker discovery. Pilots lose momentum, tools go unused, and promising initiatives fail to progress into production workflows. This pattern is observed too consistently across organizations to be attributed solely to isolated execution issues.
The Benchling 2026 Biotech AI Report shows that successful AI use cases are built on clean, verifiable data already embedded in existing workflows. Organizations with sophisticated models and mature infrastructure recognize the limiting factor is not computational capability, but data readiness.
The 2026 State of Data Integrity and AI Readiness Report surveyed more than 500 senior data and analytics leaders at large U.S. and EMEA enterprises. Eighty-eight percent reported that their organization has the data readiness needed for AI. Forty-three percent of those same leaders cited data readiness as a major obstacle to deployment. The coexistence of these perspectives highlights a fundamental issue.
When enterprises assert that their data is ready, they typically refer to centralized data lakes, established governance policies, and technically connected systems. While these are necessary conditions for enterprise AI deployment, they are insufficient in scientific R&D. However, a data lake provides limited insight into AI readiness. The true measure is whether the scientific knowledge within is structured, harmonized, and reliable enough to support models in delivering actionable insights.
For R&D organizations developing enterprise AI strategies, success depends less on model sophistication and more on aligning their scientific data layer with the operational realities of R&D.
"R&D teams that spend the next year debating which AI model to use are solving the wrong problem first. Model sophistication amplifies whatever is in the training data. A more powerful model—running on the same unresolved, decontextualized inputs—produces more severe versions of the same failures. The leverage point is upstream of the model."
— Andrea Jacobs, Director of Artificial Intelligence, CAS
AI-ready scientific data requires scientific expertise
Scientific data fundamentally differs from business data. While CRM records, financial transactions, and customer support tickets exist within well-defined, structured schemas, scientific data is multimodal, context-dependent, and complex in ways that general-purpose platforms are not designed to accommodate.
Three scientific data challenges consistently determine whether AI initiatives in R&D-intensive organizations succeed or stall:
- Proprietary experimental data often exists in incompatible formats. Instrument outputs across laboratory environments are generated in diverse file formats and metadata conventions, and identical substances, reactions, or results may be described differently across teams, sites, and systems. Without scientific expertise to normalize data before it enters an AI pipeline, models learn from disconnected information rather than a unified scientific context.
- Knowledge silos exist across scientific disciplines, intellectual property domains, and storage systems. Experimental data is stored in ELNs, literature resides in platforms like CAS SciFinder®, and molecular and assay data are maintained in disconnected internal databases. An AI system with access to only one of these sources can generate incomplete and misleading outputs that reflect only a fraction of the relevant scientific landscape.
- Regulatory traceability requirements are critical. In drug development, materials qualification, and chemical manufacturing, data must be traceable to its sources with comprehensive chain-of-custody documentation. Generic AI systems are not architected to meet these requirements, resulting in a gap between AI-generated outputs and the expectations of regulatory agencies, patent authorities, and safety databases.
When AI models are trained on inadequately curated scientific data, their outputs may appear numerically valid while being chemically implausible, biologically inconsistent, or directly contradicted by established literature.
"Reasoning and knowledge are two different capabilities. AI has made extraordinary progress in reasoning, but knowledge still depends entirely on what the model has access to, and on how well that information is structured, standardized, and verified."
— Andrea Jacobs, Director of Artificial Intelligence, CAS
Poor data readiness has compounding consequences across R&D organizations:
- Decision-making slows as teams cannot confidently act on AI-generated recommendations.
- R&D teams become reluctant to deploy AI systems beyond controlled pilot environments.
- ROI erodes as organizations continue investing in AI initiatives that cannot scale reliably across R&D workflows.
When AI-driven workflows do not achieve desired outcomes, the models are often blamed, leaving the underlying issues unaddressed in subsequent initiatives.
Aligning your scientific data foundation with your enterprise AI strategy
Organizations that successfully close the gap between AI ambition and performance recognize that scientific expertise must be embedded in the data infrastructure to produce reliable AI outputs. Achieving data readiness is not a one-time effort, though. It requires a sequenced framework with scientific expertise embedded at every step. Given that R&D teams are already stretched thin by core research priorities, that framework must operate without diverting scientific talent from their primary responsibilities.
Operationalizing enterprise AI in scientific R&D requires four foundational capabilities to make scientific knowledge reliable, connected, and usable at scale:
- A data governance model tailored to scientific knowledge. Effective governance extends beyond access controls and metadata tagging to include standardized approaches for naming, classifying, and connecting scientific entities (e.g., compounds, reactions, targets, and assay types) across systems. Each data type requires clear curation standards, with defined ownership and accountability to maintain data quality and consistency over time. When these standards are in place, AI models can learn from scientific knowledge rather than from the inconsistencies that surround it.
Integrated internal and external scientific knowledge. Proprietary experimental data is only one part of the scientific landscape. External sources, including peer-reviewed literature, patents, reaction data, and safety information, provide the context needed to validate and extrapolate internal findings. Organizations that integrate internal and external sources develop AI systems capable of reasoning across the full spectrum of relevant science, not just the subset of data they have generated internally. This connected knowledge foundation enables R&D teams to make faster and more confident decisions.
Use-case sequencing that aligns with data readiness. AI applications in R&D vary significantly in their data requirements. Literature synthesis can proceed when data is clean, while generative molecular design and predictive toxicology require multimodal, cross-team data and rigorous validation infrastructure. Organizations that align data readiness with their AI roadmap build momentum. Each use case lays the foundation for the next rather than repeatedly exposing the same underlying gaps.
Validation infrastructure embedded from the start. The quality of AI model outputs in R&D cannot be evaluated solely by standard enterprise metrics (accuracy rates, latency, uptime). Scientific outputs must also be evaluated for plausibility, consistency with established knowledge, and their ability to support confident decision-making. Incorporating domain expertise from the start reduces rework, delays, and resource expenditure that come with outputs that do not meet scientific standards.
Scaling AI without overstretching your R&D teams
Organizations that embed curation expertise into their data infrastructure, rather than relying solely on their R&D teams, are more poised to scale their AI initiatives without compromising the throughput it was intended to improve. However, building and maintaining this foundation requires deep domain expertise that most R&D organizations cannot sustain internally without pulling scientists away from core research priorities.
Partnering with organizations that specialize in scientific data curation enables R&D teams to accelerate AI readiness without diverting critical scientific talent from high-value activities. The R&D organizations pulling ahead in 2026 may not possess the most advanced models, but rather the robust scientific knowledge foundations that make those models worth deploying.